We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$93.4B
AUM Growth
+$1.44B
Cap. Flow
-$783M
Cap. Flow %
-0.84%
Top 10 Hldgs %
32.36%
Holding
7,324
New
436
Increased
3,303
Reduced
2,734
Closed
395

Sector Composition

Rank Sector Weight
1 Technology 6.12%
2 Healthcare 4.92%
3 Financials 4.07%
4 Consumer Discretionary 3.64%
5 Communication Services 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRS icon
5851
Stratus Properties
STRS
$154M
$15K ﹤0.01%
504
+475
+1,638% +$13.3K
WVE icon
5852
Wave Life Sciences
WVE
$1.2B
$15K ﹤0.01%
832
+645
+345% +$13.9K
XES icon
5853
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$364M
$15K ﹤0.01%
97
-10
-9% -$1.73K
SCTL
5854
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$15K ﹤0.01%
2,326
-12,615
-84% -$86.4K
ARNA
5855
DELISTED
Arena Pharmaceuticals Inc
ARNA
$15K ﹤0.01%
917
-13,938
-94% -$191K
STML
5856
DELISTED
Stemline Therapeutics, Inc.
STML
$15K ﹤0.01%
1,617
-975
-38% -$8.13K
BOLD
5857
DELISTED
Audentes Therapeutics, Inc
BOLD
$15K ﹤0.01%
762
-4,612
-86% -$73.7K
AGQ icon
5858
PUT
ProShares Ultra Silver
AGQ
$1.36B
$14K ﹤0.01%
400
-1,600
-80% -$58.5K
BVN icon
5859
PUT
Compañía de Minas Buenaventura
BVN
$8.67B
$14K ﹤0.01%
1,200
-9,800
-89% -$118K
CRK icon
5860
PUT
Comstock Resources
CRK
$3.94B
$14K ﹤0.01%
2,000
-18,000
-90% -$143K
CTLP
5861
DELISTED
Cantaloupe
CTLP
$14K ﹤0.01%
2,627
+2,269
+634% +$11K
FXA icon
5862
Invesco CurrencyShares Australian Dollar Trust
FXA
$98M
$14K ﹤0.01%
186
-597
-76% -$44.8K
GBX icon
5863
PUT
The Greenbrier Companies
GBX
$1.46B
$14K ﹤0.01%
+300
New +$13.7K
GSG icon
5864
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$14K ﹤0.01%
1,000
HRTX icon
5865
CALL
Heron Therapeutics
HRTX
$92.9M
$14K ﹤0.01%
1,000
MCFT icon
5866
MasterCraft Boat Holdings
MCFT
$590M
$14K ﹤0.01%
737
-12,801
-95% -$229K
PK icon
5867
CALL
Park Hotels & Resorts
PK
$2.97B
$14K ﹤0.01%
506
-176
-26% -$4.65K
RDNT icon
5868
CALL
RadNet
RDNT
$5.69B
$14K ﹤0.01%
+1,800
New +$12.3K
SBLK icon
5869
Star Bulk Carriers
SBLK
$3.22B
$14K ﹤0.01%
1,428
+1,128
+376% +$10.5K
UDN icon
5870
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
$14K ﹤0.01%
628
-81
-11% -$1.72K
UTMD icon
5871
Utah Medical Products
UTMD
$225M
$14K ﹤0.01%
201
+185
+1,156% +$12.2K
GTHX
5872
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$14K ﹤0.01%
+800
New +$14K
NS
5873
CALL
DELISTED
NuStar Energy L.P.
NS
$14K ﹤0.01%
+300
New +$14K
DBD
5874
DELISTED
Diebold Nixdorf Incorporated
DBD
$14K ﹤0.01%
462
-2,407
-84% -$66.6K
PBCT
5875
CALL
DELISTED
People's United Financial Inc
PBCT
$14K ﹤0.01%
800
+100
+14% +$1.74K

Similar funds

Barclays's Q2 2017 Portfolio in Review

As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
  • Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
  • Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
  • Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
  • Barclays opened 436 new positions and closed 395 in Q2 2017.
  • Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.